Citation sources

Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
6	6	Search

2023	The change of non-alcoholic fatty liver disease is associated with risk of incident diabetes Frontiers in Endocrinology Congling Chen, Yuecheng Zhang, Yujuan Fan, Zhen Ying, Qing Su, Xiaoying Li, Li Qin
2023	Utility of non-invasive liver fibrosis markers to predict the incidence of chronic kidney disease (CKD): A systematic review, meta-analysis, and meta-regression Diabetes & Metabolic Syndrome: Clinical Research & Reviews Rudi Supriyadi, Theo Audi Yanto, Timotius Ivan Hariyanto, Ketut Suastika
2021	Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect World Journal of Gastroenterology Rajiv Heda, Masahiko Yazawa, Michelle Shi, Madhu Bhaskaran, Fuad Zain Aloor, Paul J Thuluvath, Sanjaya K Satapathy
2021	Non-invasive fibrosis assessments of non-alcoholic fatty liver disease associated with low estimated glomerular filtration rate among CKD patients: the Fukuoka Kidney disease Registry Study Clinical and Experimental Nephrology Masatoshi Hara, Shigeru Tanaka, Kumiko Torisu, Yuta Matsukuma, Akihiro Tsuchimoto, Masanori Tokumoto, Hiroaki Ooboshi, Toshiaki Nakano, Kazuhiko Tsuruya, Takanari Kitazono
2021	Nonalcoholic Fatty Liver Disease and the Kidney: A Review Biomedicines Ilaria Umbro, Francesco Baratta, Francesco Angelico, Maria Del Ben
2021	High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes Scientific Reports Haruka Saito, Hayato Tanabe, Akihiro Kudo, Noritaka Machii, Moritake Higa, Satoshi Yamaguchi, Gulinu Maimaituxun, Kazumichi Abe, Atsushi Takahashi, Kenichi Tanaka, Koichi Asahi, Hiroaki Masuzaki, Hiromasa Ohira, Junichiro J. Kazama, Michio Shimabukuro